| Primary |
| Rheumatoid Arthritis |
54.8% |
| Product Used For Unknown Indication |
11.0% |
| Psoriatic Arthropathy |
7.4% |
| Ankylosing Spondylitis |
6.8% |
| Prophylaxis |
5.1% |
| Hypertension |
3.2% |
| Pain |
1.6% |
| Arthritis |
1.5% |
| Osteoporosis |
1.4% |
| Ill-defined Disorder |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Diabetes Mellitus |
0.8% |
| Blood Pressure |
0.7% |
| Depression |
0.7% |
| Psoriasis |
0.6% |
| Asthma |
0.6% |
| Hypothyroidism |
0.5% |
| Colitis Ulcerative |
0.5% |
| Thyroid Disorder |
0.5% |
| Crohn's Disease |
0.5% |
|
| Pneumonia |
25.5% |
| Vomiting |
5.8% |
| Herpes Zoster |
5.4% |
| Cellulitis |
5.3% |
| Drug Dose Omission |
5.3% |
| Infection |
5.3% |
| Urinary Tract Infection |
4.6% |
| Pyrexia |
4.5% |
| Pain |
3.7% |
| Tuberculosis |
3.5% |
| Sepsis |
3.4% |
| Weight Decreased |
3.4% |
| Neoplasm Malignant |
3.3% |
| Death |
3.1% |
| Drug Ineffective |
3.1% |
| Dyspnoea |
3.1% |
| Rheumatoid Arthritis |
3.1% |
| Skin Cancer |
3.1% |
| Breast Cancer |
3.0% |
| Headache |
2.9% |
|
| Secondary |
| Rheumatoid Arthritis |
66.9% |
| Prophylaxis |
9.7% |
| Product Used For Unknown Indication |
5.4% |
| Psoriatic Arthropathy |
4.4% |
| Ankylosing Spondylitis |
2.7% |
| Hypertension |
2.1% |
| Osteoporosis |
1.6% |
| Psoriasis |
0.8% |
| Pain |
0.8% |
| Arthritis |
0.7% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Crohn's Disease |
0.6% |
| Insomnia |
0.5% |
| Seronegative Arthritis |
0.5% |
| Diabetes Mellitus |
0.5% |
| Constipation |
0.5% |
| Asthma |
0.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.4% |
| Depression |
0.4% |
| Gastritis |
0.3% |
|
| Pneumonia |
18.5% |
| Vomiting |
6.9% |
| Tuberculosis |
6.5% |
| Cell Marker Increased |
5.9% |
| Bronchopneumonia |
5.3% |
| Pyelonephritis |
5.1% |
| Urinary Tract Infection |
4.8% |
| Herpes Zoster |
4.7% |
| Rheumatoid Arthritis |
4.7% |
| Drug Ineffective |
4.1% |
| Renal Disorder |
4.1% |
| Hepatic Function Abnormal |
3.9% |
| Liver Disorder |
3.8% |
| Pyrexia |
3.6% |
| Interstitial Lung Disease |
3.3% |
| Keloid Scar |
3.3% |
| Pneumocystis Jirovecii Pneumonia |
3.2% |
| White Blood Cell Count Decreased |
3.0% |
| Syncope |
2.9% |
| Pneumonia Bacterial |
2.7% |
|
| Concomitant |
| Rheumatoid Arthritis |
31.7% |
| Product Used For Unknown Indication |
19.7% |
| Psoriatic Arthropathy |
13.1% |
| Ankylosing Spondylitis |
8.2% |
| Psoriasis |
7.9% |
| Hypertension |
2.3% |
| Arthritis |
2.1% |
| Pain |
2.1% |
| Tendonitis |
1.5% |
| Breakthrough Pain |
1.3% |
| Nausea |
1.3% |
| Vitamin Supplementation |
1.3% |
| Muscle Relaxant Therapy |
1.1% |
| Osteoarthritis |
1.1% |
| Arthralgia |
1.0% |
| Hepatitis C |
1.0% |
| Inflammation |
1.0% |
| Depression |
0.8% |
| Fibromyalgia |
0.8% |
| Inflammatory Bowel Disease |
0.8% |
|
| Drug Ineffective |
16.1% |
| Therapeutic Response Decreased |
13.5% |
| Rheumatoid Arthritis |
6.5% |
| Psoriasis |
5.8% |
| Sinusitis |
5.8% |
| Injection Site Reaction |
5.2% |
| Pain |
5.2% |
| Pain In Extremity |
5.2% |
| Wrong Technique In Drug Usage Process |
4.5% |
| Injection Site Pain |
3.9% |
| Injection Site Swelling |
3.9% |
| Musculoskeletal Stiffness |
3.2% |
| Urticaria |
3.2% |
| Arthralgia |
2.6% |
| Injection Site Warmth |
2.6% |
| Malaise |
2.6% |
| Psoriatic Arthropathy |
2.6% |
| Rash |
2.6% |
| Squamous Cell Carcinoma |
2.6% |
| Swelling |
2.6% |
|
